<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01589588</url>
  </required_header>
  <id_info>
    <org_study_id>H-2-2011-163</org_study_id>
    <nct_id>NCT01589588</nct_id>
  </id_info>
  <brief_title>Administration of Oxygen to Cluster Headache Patients</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mads Barløse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Danish Headache Center</source>
  <brief_summary>
    <textblock>
      This study will investigate the possible difference in treatment effect between three
      different oxygen delivery systems in the acute treatment of cluster headaches.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy</measure>
    <time_frame>15 minutes</time_frame>
    <description>Pain relief after 15 minutes of treatment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mask preference</measure>
    <time_frame>2 days</time_frame>
    <description>subject mask preference</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">57</enrollment>
  <condition>Cluster Headache Attacks</condition>
  <arm_group>
    <arm_group_label>Mask 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Mask 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Mask 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Mask 3, placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Open Hudson Mask</intervention_name>
    <description>Mask type 1 oxygen</description>
    <arm_group_label>Mask 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cluster headache mask with 3 L reservoir</intervention_name>
    <description>Mask type 2 with oxygen</description>
    <arm_group_label>Mask 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Mask 3</intervention_name>
    <description>Mask type 3 oxygen</description>
    <arm_group_label>Mask 3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Carnét oxygen demand valve</intervention_name>
    <description>mask type 3 oxygen</description>
    <arm_group_label>Mask 3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Carnét oxygen demand valve</intervention_name>
    <description>mask type 3 placebo</description>
    <arm_group_label>Mask 3, placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  episodic cluster headache

          -  regular occurance of attacks and cluster for 2 years

          -  2-8 attacks / day

          -  cluster periods of over 14 days

          -  duration of current cluster period max 14 days

          -  ability to differentiate between attacks of CH and other forms of headache

        Exclusion Criteria:

          -  Changes in prophylactic treatment a week before trial

          -  pregnancy or breastfeeding women

          -  serious somatic or psychiatric disease

          -  COLD

          -  chronic or primary or secondary headache &gt; 14 days / month other than CH

          -  alcohol abuse
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Danish Headache Center</name>
      <address>
        <city>Glostrup</city>
        <zip>2600</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 26, 2012</study_first_submitted>
  <study_first_submitted_qc>April 30, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 2, 2012</study_first_posted>
  <last_update_submitted>October 9, 2015</last_update_submitted>
  <last_update_submitted_qc>October 9, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 12, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Danish Headache Center</investigator_affiliation>
    <investigator_full_name>Mads Barløse</investigator_full_name>
    <investigator_title>MD, principal investigator</investigator_title>
  </responsible_party>
  <keyword>acute treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Headache</mesh_term>
    <mesh_term>Cluster Headache</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

